Clinical trials in Groningen – page 4

557 clinical trials in Groningen, The Netherlands across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in the NetherlandsKlinischOnderzoek.nl

Groningen at a glance

557

clinical trials

Research sites8

Quick filters

557 trials in Groningen

Open in trial search

Inflammatory bowel disease+1

Recruiting

Registered drug

Modafinil for Severe Fatigue in Patients with Quiescent Inflammatory Bowel Disease

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Modafinil
Sponsor:Stichting Radboud universitair medisch centrum

Contact Research Centre

Kidney transplant rejection

Recruiting

Registered drugNo placebo

Frexalimab versus Tacrolimus for Prevention of Kidney Transplant Rejection in Adult Kidney Transplant Recipients

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Frexalimab
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Immunoglobulin G4 related disease

Recruiting

Investigational

A study to evaluate the efficacy and safety of rilzabrutinib in adults with active IgG4-related disease

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Gastric cancer+4

Recruiting

InvestigationalNo placebo

A study to evaluate the use of [68Ga]BED003 for imaging colorectal, gastric, pancreatic, breast, and ovarian cancers.

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years

Contact Research Centre

Ovarian cancer

Recruiting

Registered drugNo placebo

Phase 3 Study of INCB123667 versus investigator's choice of chemotherapy drug combination in patients with platinum‑resistant ovarian cancer and cyclin E1 overexpression

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:INCB123667
Sponsor:Incyte Corp.

Contact Research Centre

Small cell lung cancer metastatic

Recruiting

InvestigationalNo placebo

Phase II Study of Intravenous Tarlatamab for Patients with Asymptomatic Brain Metastases from Small Cell Lung Cancer

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Tarlatamab
Sponsor:Academisch Ziekenhuis Maastricht

Contact Research Centre

Crohn's disease

Recruiting

Registered drugNo placebo

An observational study on the use of methotrexate in children and adolescents with Crohn's disease

Registered drugNo placebo

The Netherlands

Participants:0–17 years · 18–64 years
Substances:Methotrexate
Sponsor:Amsterdam UMC Stichting

Contact Research Centre

Triple negative breast cancer

Recruiting

Registered drugNo placebo

Study of pembrolizumab, capecitabine, or olaparib in patients with early-stage triple negative breast cancer and remaining disease after initial treatment

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting

Contact Research Centre

Acute lymphocytic leukaemia

Recruiting

Registered drugNo placebo

Study of Blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Asparaginase
Sponsor:Amgen Inc.

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Comparing Sotorasib and Pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Calcium Folinate
Sponsor:Amgen Inc.

Contact Research Centre

Cardiovascular disorder+2

Recruiting

Registered drugNo placebo

A study to compare the effects of BI 690517 and spironolactone on kidney function in patients with heart failure, cardiovascular disease, or chronic kidney disease

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Bi 690517
Sponsor:Universitair Medisch Centrum Groningen

Contact Research Centre

Bile duct cancer

Recruiting

Registered drugNo placebo

A study of rilvegostomig, cisplatin, and gemcitabine compared to durvalumab and a drug combination for adults with advanced biliary tract cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Cisplatin
Sponsor:AstraZeneca AB

Contact Research Centre

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in Groningen

What the registry says about research in the country

01 Cardiovascular Research

Advanced studies focusing on heart disease and cardiovascular conditions, including innovative treatments for ATTR amyloidosis and prevention strategies for heart failure.

Cardiomyopathy Treatments
Heart Failure Prevention
Peripheral Arterial Disease

Multiple trials exploring novel therapeutic approaches and preventive measures for various cardiac conditions.

02 Oncology Studies

Comprehensive research into various cancer types, including melanoma and lung cancer, with particular focus on innovative treatment approaches and metastatic disease management.

Advanced Breast Cancer
Small Cell Lung Cancer
Brain Metastases

Investigation of targeted therapies and combination treatments for improved patient outcomes.

03 Metabolic Disorders

Clinical investigations focusing on obesity and type 2 diabetes, testing new therapeutic approaches for weight management and metabolic control.

Weight Management
Diabetes Treatment
Metabolic Health

Evaluation of novel medications combined with lifestyle interventions for optimal patient care.

Back to the Netherlands All countries